Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
2 studies found for:    18024863 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Recruiting Dasatinib in Combination With Bevacizumab to Treat Advanced Solid Tumors
Condition: Solid Tumors
Interventions: Drug: Bevacizumab;   Drug: Dasatinib
2 Completed
Has Results
Trial of Pemetrexed and Bevacizumab for Recurrent Ovarian Primary Peritoneal Carcinoma
Conditions: Ovarian Carcinoma;   Primary Peritoneal Carcinoma
Interventions: Drug: Pemetrexed;   Drug: Bevacizumab

Indicates status has not been verified in more than two years